r.lehtinen
Submits third-party assay reports on material purchased directly. Based in Osaka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.63%
n=6
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041660 | Semaglutide | QSC | QSC-2511-M9226 | Janoshik | 2026-Q2 | 99.11 | 4.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042901 | Semax | MKM | MKM-2512-B2992 | Janoshik | 2026-Q2 | 99.03 | 7.24 | 99.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042371 | CJC-1295 with DAC | SWB | SWB-2510-N4367 | Nordanalyt | 2026-Q1 | 97.74 | 2.66 | 95.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019922 | IGF-1 LR3 | SWB | SWB-2505-N5257 | Janoshik | 2025-Q4 | 97.33 | 6.54 | 94.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019434 | Semaglutide | Homopeptide | HOMO-2506-V8763 | Janoshik | 2025-Q3 | 98.77 | 5.37 | 103.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004408 | Retatrutide | QSC | QSC-2408-X8779 | Janoshik | 2024-Q4 | 98.50 | 5.82 | — | Supplier-supplied | 1 | MARGINAL |
| Supplier | Records | Median purity |
|---|---|---|
| QSC | 2 | n<3 |
| SWB | 2 | n<3 |
| MKM | 1 | n<3 |
| Homopeptide | 1 | n<3 |